Studies have suggested that MetS status was associated with elevated levels of inflammatory factors, reactive oxygen, and serum insulin-like growth factor 1 (IGF-1), which might provide a protumorigenic environment and are risk factors for bladder cancer (11–16). Here, IGF1 is linked to metabolic syndrome.